Walk into a gas station, smoke shop or wellness bar today and you are likely to find neatly branded shots, powders and gummies labeled “kratom” or “kava,” marketed as plant‑based ways to boost energy, ease stress or unwind at the end of the day. For millions of people, especially those looking for alternatives to alcohol, prescription painkillers or stronger sedatives, these products have become part of a daily routine rather than a fringe experiment. While experts stress that “natural” does not automatically mean harmless, emerging research and decades of traditional use suggest that kratom and kava can play a relatively safe role for some adults when used thoughtfully, at moderate doses and with attention to product quality.
What kratom and kava actually are
Kratom comes from the leaves of Mitragyna speciosa, a tropical tree native to countries like Indonesia, Thailand and Malaysia, where farmers and laborers have long chewed fresh leaves or brewed them into tea to fight fatigue and work longer hours. At lower amounts, kratom is typically experienced as a mild stimulant, similar in spirit to a very strong coffee, while higher amounts can bring more relaxing, pain‑relieving, opioid‑like effects. This dose‑dependent profile helps explain why some people reach for kratom to get through a shift, while others take evening doses to manage chronic pain or sleep.
Kava, prepared from the root of Piper methysticum, has a different cultural and pharmacological story. In Pacific Island nations, water‑based kava drinks have been used ceremonially and socially for generations to promote relaxation and sociability without the disinhibition and hangover of alcohol. The World Health Organization has noted that traditionally prepared, water‑extracted kava consumed in customary settings appears to carry relatively low short‑term health risks, a key reason many Pacific governments continue to support regulated traditional use.
How people are using them now
In the United States, both kratom and kava have moved far beyond their original cultural contexts, showing up as capsules, flavored powders, sweetened “relaxation” shots, canned beverages and even products that blend the two plants. Many of the people who use them are not chasing a high; observational surveys find common motives include improving mood, easing anxiety, boosting energy, managing chronic pain and, importantly, reducing or replacing alcohol or opioid use. In several large online surveys of Western kratom consumers, respondents overwhelmingly reported that kratom helped them stay functional—going to work, caring for family and meeting responsibilities that felt impossible on other medications or illicit drugs.
Kava has carved out a niche in “kava bars” across the country, where patrons sip shells of earthy‑tasting root tea instead of cocktails. Regulars often describe it as a way to get the social, calming vibe of a bar without the intoxication or aggression that can accompany alcohol, and some addiction clinicians now see kava lounges as one of several “safer social spaces” for people in recovery from alcohol use disorder.
What kratom does in the body
Kratom’s complex but intriguing pharmacology is at the heart of its appeal. Its leaf contains dozens of active alkaloids, with mitragynine the most abundant and 7‑hydroxymitragynine a much more potent but normally minor component. Both interact with mu‑opioid receptors—the same receptors targeted by prescription painkillers—but mitragynine also influences other systems, including serotonin, dopamine and norepinephrine. In practice, that means many users experience a clear, energizing effect at lower doses and more pronounced pain relief and relaxation at higher doses, often without the heavy respiratory suppression that makes full‑agonist opioids so dangerous.
Modern research is beginning to catch up to what Southeast Asian communities have observed for generations. Laboratory work has shown that kratom can increase pain tolerance in controlled settings, supporting the many user reports that it helps with chronic pain. A recent review in a toxicology journal described both beneficial and adverse health effects, but emphasized that in traditional settings kratom has long been used to relieve symptoms ranging from pain and cough to diarrhea and sleeplessness. The U.S. National Institute on Drug Abuse (NIDA) now supports studies exploring kratom‑derived compounds as possible tools to manage chronic pain and even help with opioid withdrawal, reflecting growing recognition that the plant’s pharmacology could be harnessed in more precise, medical ways.
Kava’s gentler, targeted profile
Kava works through a different suite of compounds—kavalactones—which appear to modulate GABA and other neurotransmitter systems linked to anxiety and muscle tension. Clinical trials using standardized kava preparations have found modest but meaningful reductions in anxiety symptoms in some patients, with a side‑effect profile that, in controlled doses and durations, compares favorably with certain prescription sedatives. For many people who are wary of benzodiazepines or other heavy tranquilizers, kava represents a plant‑based option that can take the edge off stress without clouding thinking or coordination to the same extent.
Crucially, the World Health Organization and several national health agencies have drawn a distinction between traditional, water‑based kava drinks and more concentrated or solvent‑extracted products. Traditional beverages, consumed in community settings with strong social norms around frequency and quantity, have historically seen relatively few serious harms, which is why some countries have reviewed their kava policies in light of new data and cultural context.
Safety, risk and the role of context
Any honest discussion of safe use has to address risk, but the picture for kratom is more nuanced than many headlines suggest. The U.S. Food and Drug Administration has not approved kratom for any medical use and has raised concerns about contamination and rare serious adverse events, particularly when products are adulterated or combined with other drugs. At the same time, public‑health data show that in overdose cases where kratom is detected, it is usually one substance among several, often including fentanyl, heroin or benzodiazepines which are far more strongly linked with fatal outcomes. Researchers who reviewed decades of international data concluded that, for people already using high‑risk opioids, kratom often appears to function as a milder, less lethal alternative, and that its risks and benefits must be weighed against real‑world comparators, not an ideal of zero drug use.
For everyday consumers, the most practical safety issues are straightforward: product quality, dose and combinations. Because kratom is not regulated like a medicine, some products have been found to contain heavy metals or bacteria such as Salmonella, underlining the importance of choosing vendors who publish lab testing and follow basic quality standards. Observational studies suggest that many long‑term users maintain stable, moderate dosing patterns and report more benefits than harms, especially when they avoid mixing kratom with alcohol, opioids or sedative medications.
Dependence and real‑world treatment
Kratom can cause dependence, particularly with heavy, frequent use of strong extracts, but the profile again appears different—and often milder—than that of full‑agonist opioids. Nebraska Medicine addiction psychiatrist Sara Zachman, MD, MPH, notes that people seeking help for kratom problems often began using it for understandable reasons—pain, focus, anxiety or to cut down on other substances—and gradually escalated to round‑the‑clock dosing. When dependence develops, clinicians frequently use the same toolkit applied to opioid use disorder: careful tapering, psychosocial support and, in some cases, medications like buprenorphine‑naloxone to ease withdrawal and cravings. Early case reports and clinical experience suggest that patients with kratom dependence typically stabilize and improve with treatment, especially when co‑occurring mental‑health conditions and pain are addressed at the same time.
By comparison, kava appears less likely to produce a classic addiction pattern, and most concerns center on liver health when high‑dose supplements or non‑traditional extracts are used over long periods, particularly alongside alcohol or other hepatotoxic drugs. For people with healthy livers who use traditional water‑based kava occasionally, the available evidence points to a relatively favorable short‑term safety profile, something the World Health Organization has explicitly acknowledged.
Why people turn to kratom in the first place
One of the most important points, often lost in polarized debates, is why people are reaching for kratom at all. Surveys of thousands of users in both Southeast Asia and the West paint a consistent picture: individuals use kratom to boost energy and productivity, manage chronic pain, ease anxiety and depression, and, critically, reduce or stop using opioids, alcohol and other drugs. In a large analysis summarized by the University of Rochester Medical Center, researchers found that much of the available evidence supports kratom’s role as a milder, less addictive and less dangerous substance than conventional opioids for many users, while emphasizing the need for continued, rigorous study.
NIDA now explicitly recognizes these patterns, noting that many people report using kratom to alleviate opioid withdrawal symptoms and cravings, to cope with pain and to manage mental‑health concerns when other treatments have fallen short. Federal research programs, including the NIH HEAL Initiative, are funding work on kratom‑related compounds as potential treatments for pain and opioid use disorder, a strong signal that public‑health agencies increasingly see the plant not only as a risk to be managed but also as a possible tool to reduce harm in the midst of an ongoing overdose crisis.
Making informed, safer choices
For adults considering kratom or kava, the safest path starts with accurate information rather than marketing slogans or alarmist myths. Medical centers such as Nebraska Medicine urge would‑be users to talk openly with their clinicians, especially if they have liver disease, are pregnant, take prescription medications or have a history of substance use disorder. National resources like the Substance Abuse and Mental Health Services Administration’s 1‑800‑662‑HELP line can connect people to providers who understand both the risks and the real‑world reasons people turn to these plants.
Used in isolation, at modest doses and from reputable sources, kratom and kava occupy a middle ground in the drug landscape: not benign herbs to be taken casually, but not the unmanageable menace they are sometimes portrayed to be. The growing body of research, alongside centuries of traditional practice, points to a future in which kratom in particular may be refined into safer, standardized tools for pain and addiction treatment—provided policymakers, scientists and consumers allow room for nuance instead of all‑or‑nothing thinking.